Hatfield, Stephen M <br/><br/>
A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer.  [electronic resource] 

 -  Current opinion in pharmacology  08 2016 
 - 90-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1471-4973 
<br/><br/><label>Standard No.: </label>10.1016/j.coph.2016.06.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine--metabolism<br/>Adenosine A2 Receptor Antagonists--pharmacology<br/>Animals<br/>Humans<br/>Hypoxia-Inducible Factor 1, alpha Subunit--immunology<br/>Immune Tolerance--immunology<br/>Immunotherapy--methods<br/>Killer Cells, Natural--immunology<br/>Neoplasms--drug therapy<br/>Signal Transduction--immunology<br/>T-Lymphocytes--immunology<br/>Tumor Microenvironment--immunology